Autoimmunity may play a role in the pathogenesis of POTS in some patients, but a single causative antibody has not been identified. Antibody testing currently is recommended only when considering an alternative diagnosis.
Case report: A 30-year-old patient experiences progressive sensory loss starting with his hands. Collaboration between Cleveland Clinic neurologists and rheumatologists leads to diagnosis and treatment.
A multigenerational analysis using the Utah Population Database suggests shared genetic predisposition between stiff-person spectrum disorder and other autoimmune conditions.
Soon after her diagnosis of COVID-19, a patient began to experience severe allodynia to light touch over her forearms and shins.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Our expert shares the essentials of evaluating and managing encephalitis and other neurologic disorders of suspected autoimmune origin.
While diagnosing iSGS can be challenging, treatments for the condition have advanced in recent years.
While recognition of autoimmune encephalitis has increased substantially, autoimmune causality is still overlooked for many subtle neurologic abnormalities. A subspecialist provides an update on autoimmune neurology.
Flu season is here, and the stakes are especially high for patients with autoimmune diseases. Rheumatologists Cassandra Calabrese, DO, and Leonard Calabrese, DO, address common patient concerns about the influenza vaccine and share best practices for maximizing vaccination coverage.
A recent study finds hydroxychloroquine shows promise in secondary prevention of congenital heart block for pregnant women with autoimmune disease. Maternal-fetal medicine specialist Jeff Chapa, MD, and pediatric cardiologist Peter Aziz, MD, explain.
Complex immunologic disease requires collaboration across subspecialties. Cleveland Clinic’s first dual-trained rheumatology-infectious disease specialist explains why we need more rheum-ID hybrids.